CLBT — Cellebrite DI Cashflow Statement

0.000.00%

Last trade - 00:00

TechnologyAdventurousLarge CapNeutral

Annual cashflow statement for Cellebrite DI, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	20-F	20-F	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	71.4	121	-81.1	-283	78.3
Depreciation
Deferred Taxes
Non-Cash Items	-61.4	-104	130	367	36.7
Unusual Items
Other Non-Cash Items
Changes in Working Capital	20.7	-2.82	38.5	42	46.6
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	36.1	20.6	102	132	174
Capital Expenditures	-8.11	-9.09	-7.92	-10.6	-13.2
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	53.3	-82.1	-14.6	-139	-255
Acquisition of Business
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Cash from Investing Activities	45.2	-91.2	-22.5	-149	-268
Financing Cash Flow Items	29.3	0	0	—	—
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Cash from Financing Activities	-68.4	14	21.8	20.7	25.1
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	12.1	-58.3	102	2.14	-67.2